Dr. Paul Thuluvath, MBBS, MD, FRCP
Claim this profileMercy Medical Center
Studies Liver Fibrosis
Studies Liver Cirrhosis
8 reported clinical trials
11 drugs studied
Affiliated Hospitals
Clinical Trials Paul Thuluvath, MBBS, MD, FRCP is currently running
Lanifibranor
for Nonalcoholic Steatohepatitis (NASH)
This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
Recruiting1 award Phase 31 criteria
INT-787
for Alcoholic Hepatitis
This trial tests a new drug called INT-787 for people with severe liver damage from heavy drinking. It aims to see if the drug is safe and effective, and how the body processes it. The goal is to find out if INT-787 can help improve liver health in these patients. Previous studies have shown that similar treatments can protect against liver injury.
Recruiting0 awards Phase 2
More about Paul Thuluvath, MBBS, MD, FRCP
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Paul Thuluvath, MBBS, MD, FRCP has experience with
- Placebo
- Heplisav-B Injectable Product
- Belapectin
- AXA1665
- INT-787
- Bezafibrate
Breakdown of trials Paul Thuluvath, MBBS, MD, FRCP has run
Liver Fibrosis
Liver Cirrhosis
Entecavir for Hepatitis B
Fibrosing Colonopathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Thuluvath, MBBS, MD, FRCP specialize in?
Paul Thuluvath, MBBS, MD, FRCP focuses on Liver Fibrosis and Liver Cirrhosis. In particular, much of their work with Liver Fibrosis has involved treating patients, or patients who are undergoing treatment.
Is Paul Thuluvath, MBBS, MD, FRCP currently recruiting for clinical trials?
Yes, Paul Thuluvath, MBBS, MD, FRCP is currently recruiting for 3 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Paul Thuluvath, MBBS, MD, FRCP has studied deeply?
Yes, Paul Thuluvath, MBBS, MD, FRCP has studied treatments such as Placebo, Heplisav-B Injectable Product, Belapectin.
What is the best way to schedule an appointment with Paul Thuluvath, MBBS, MD, FRCP?
Apply for one of the trials that Paul Thuluvath, MBBS, MD, FRCP is conducting.
What is the office address of Paul Thuluvath, MBBS, MD, FRCP?
The office of Paul Thuluvath, MBBS, MD, FRCP is located at: Mercy Medical Center, Baltimore, Maryland 21202 United States. This is the address for their practice at the Mercy Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.